Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the section of Clinical Epidemiology at Boston University School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She is a Member of the Spondyloarthritis Research and Treatment Network (SPARTAN), and of the Assessment of Spondyloarthritis International Society (ASAS), and serves on the the Early Career Investigator Subcommittee of the American College of Rheumatology.
- Active Staff Hospital Privileges, Rheumatology, Boston Medical Center
- VA Boston Healthcare System
- BU Profile
- Publications (PubMed)
- BU Rheumatology
- BU Clinical Epidemiology Research and Training Unit
- Boston Medical Center- Rheumatology Clinic
- VA Boston Healthcare System Rheumatology Clinic
- SPARTAN (Spondyloarthritis Research and Treatment Network)
- American College of Rheumatology National Meeting Abstracts
- European League Against Rheumatism Meeting Abstracts
- Spondylitis Association of America
- University of Connecticut School of Medicine, MD
- Rochester Institute of Technology, BS
- Published on 6/16/2018
Dubreuil M, Louie-Gao Q, Peloquin C, Choi HK, Zhang Y, Neogi T. Response to: 'Association between use of non-steroidal anti-inflammatory drugs and risk of myocardial infarction in patients with spondyloarthritis and osteoarthritis'. Ann Rheum Dis. 2018 Jun 16. PMID: 29909375.
- Published on 5/7/2018
Dubreuil M, Sieper J. Editorial: Inflammatory Back Pain and Axial Spondyloarthritis: Lessons for Clinical Practice and Epidemiologic Research. Arthritis Rheumatol. 2018 Jul; 70(7):981-983. PMID: 29471586.
- Published on 5/1/2018
Jinno S, Sulis CA, Dubreuil MD. Causative Pathogens, Antibiotic Susceptibility, and Characteristics of Patients with Bacterial Septic Arthritis over Time. J Rheumatol. 2018 May; 45(5):725-726. PMID: 29717095.
- Published on 4/19/2018
Dubreuil M, Louie-Gao Q, Peloquin CE, Choi HK, Zhang Y, Neogi T. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis. 2018 Apr 19. PMID: 29674321.
- Published on 2/18/2018
Jinno S, Lu N, Jafarzadeh SR, Dubreuil M. Trends in Hospitalizations for Serious Infections in Patients With Rheumatoid Arthritis in the US Between 1993 and 2013. Arthritis Care Res (Hoboken). 2018 Apr; 70(4):652-658. PMID: 28732148.
- Published on 11/4/2017
Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, Gelfand JM, LaValley MP, Dubreuil M, Sparks JA, Karlson EW, Choi HK. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018 Jan; 77(1):119-123. PMID: 29102956.
- Published on 10/13/2017
Dalal D, Dubreuil M, Peloquin C, Neogi T, Zhang Y, Choi H, Felson D. Meloxicam and risk of myocardial infarction: a population-based nested case-control study. Rheumatol Int. 2017 Dec; 37(12):2071-2078. PMID: 29030657.
- Published on 7/11/2017
Oza A, Lu N, Schoenfeld SR, Fisher MC, Dubreuil M, Rai SK, Zhang Y, Choi HK. Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study. Ann Rheum Dis. 2017 Oct; 76(10):1737-1742. PMID: 28698231.
- Published on 7/1/2017
Deodhar AA, Kumthekar A, Dubreuil M. Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development. Curr Opin Rheumatol. 2017 Jul; 29(4):293-297. PMID: 28376060.
- Published on 7/1/2017
Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017 Jul; 29(4):317-322. PMID: 28376062.
View 15 more publications: View full profile at BUMC